4-苄氧基-2-甲基苯腈 | 914296-76-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 4-苄氧基-2-甲基苯腈
• 英文名称: 4-(benzyloxy)-2-methylbenzonitrile
• 英文别名: 4-Benzyloxy-2-methylbenzonitrile；2-methyl-4-phenylmethoxybenzonitrile
• CAS: 914296-76-7
• 化学式: C₁₅H₁₃NO
• 分子量: 223.274
• InChiKey: OSIOXCXSSBBDME-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  33
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-苄氧基-2-甲基苯腈 在 palladium dihydroxide 盐酸 、 tris(dibenzylideneacetone)dipalladium (0) 、 氢气 、 双(三甲基硅烷基)氨基钾 、 caesium carbonate 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 、 肼 、 锌 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 生成 3-(4-amino-2-methylphenyl)-4,4-dimethyl-1H-pyrazol-5-one
  参考文献：
  名称：

  Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors

  摘要：

  Aryldihydropyridazinones and aryldimethylpyrazolones with 2-benzyl vinylogous amide substituents have been identified as potent PDE3B subtype selective inhibitors. Dihydropyridazinone 8a (PDE3B IC50 = 0.19 nM, 3A IC50 = 1.3 nM) was selected for in vivo evaluation of lipolysis induction, metabolic rate increase, and cardiovascular effects. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.08.056
• 作为产物：
  描述：

  4-羟基-2-甲基苯甲腈 、 溴甲苯 在 四丁基碘化铵 、 sodium hydride 作用下， 以 四氢呋喃 为溶剂， 生成 4-苄氧基-2-甲基苯腈
  参考文献：
  名称：

  Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors

  摘要：

  Aryldihydropyridazinones and aryldimethylpyrazolones with 2-benzyl vinylogous amide substituents have been identified as potent PDE3B subtype selective inhibitors. Dihydropyridazinone 8a (PDE3B IC50 = 0.19 nM, 3A IC50 = 1.3 nM) was selected for in vivo evaluation of lipolysis induction, metabolic rate increase, and cardiovascular effects. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2003.08.056

文献信息

• [EN] COMPOUNDS AND METHODS<br/>[FR] COMPOSÉS ET MÉTHODES
  申请人：TEMPERO PHARMACEUTICALS INC

  公开号：WO2013019682A1

  公开（公告）日：2013-02-07

  The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORy.

  本发明涉及新型视黄醛酸相关孤儿受体γ（RORγ）调节剂及其在治疗由RORγ介导的疾病中的应用。
• Selective para-Cyanation of Alkoxy- and Benzyloxy-Substituted Benzenes with Potassium Ferricyanide Promoted by Copper(II) Nitrate and Iodine
  作者：Yunlai Ren、Mengjie Yan、Shuang Zhao、Jianji Wang、Junying Ma、Xinzhe Tian、Weiping Yin

  DOI：10.1002/adsc.201200235

  日期：2012.8.13

  A simple method was developed for selective para-cyanation of alkoxy- and benzyloxy-substituted benzenes with 0.5 equivalents of potassium ferricyanide, 0.8 equivalants of copper(II) nitrate and 0.5 equivalents of iodine in acetonitrile. Among various phenyl carbon-hydrogen bonds, those at the para-position with regard to the alkoxy or benzyloxy groups were selectively cyanated in 20% to 87% yields

  一个简单的方法，用于选择性地开发对用0.5当量的铁氰化钾，硝酸铜0.8 equivalants和在乙腈中的0.5当量的碘的烷氧基和苄氧基-取代的苯的-cyanation。在各种苯基碳氢键中，相对于烷氧基或苄氧基处于对位的那些被选择性氰化，产率为20％至87％（23个例子）。本方法使用可商购的试剂，并且可以以十克规模进行。有趣的是，在不存在铁氰化钾的情况下，甲氧基苯以32％的产率氰化，这表明一部分产品的腈基可能来自溶剂乙腈。
• Metal-Free Regioselective Monocyanation of Hydroxy-, Alkoxy-, and Benzyloxyarenes by Potassium Thiocyanate and Silica Sulfuric Acid as a Cyanating Agent
  作者：Ali Reza Sardarian、Iman Dindarloo Inaloo、Ali Reza Modarresi-Alam、Erich Kleinpeter、Uwe Schilde

  DOI：10.1021/acs.joc.8b02191

  日期：2019.2.15

  A novel and efficient metal- and solvent-free regioselective para-C–H cyanation of hydroxy-, alkoxy-, and benzyloxyarene derivatives has been introduced, using nontoxic potassium thiocyanate as a cyanating reagent in the presence of silica sulfuric acid (SSA). The desired products are obtained in good to high yields without any toxic byproducts.

  引入了一种新颖，有效的无金属和无溶剂的羟基，烷氧基和苄氧基芳烃衍生物的对-C-H氰化氰化物，在二氧化硅硫酸（SSA）存在下，使用无毒的硫氰酸钾作为氰化试剂。所需产物以高至高收率获得，没有任何有毒副产物。
• COMPOUNDS AND METHODS
  申请人：Baloglu Erkan

  公开号：US20140155381A1

  公开（公告）日：2014-06-05

  The present invention relates to novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.

  本发明涉及新型視黃醇相關孤兒核受體γ（RORγ）調節劑及其在治療由RORγ介導的疾病中的使用。
• Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors
  作者：Scott D. Edmondson、Anthony Mastracchio、Jiafang He、Christine C. Chung、Michael J. Forrest、Scott Hofsess、Euan MacIntyre、Joseph Metzger、Naphtali O'Connor、Kajal Patel、Xinchun Tong、Michael R. Tota、Lex H.T. Van der Ploeg、Jeff P. Varnerin、Michael H. Fisher、Matthew J. Wyvratt、Ann E. Weber、Emma R. Parmee

  DOI：10.1016/j.bmcl.2003.08.056

  日期：2003.11

  Aryldihydropyridazinones and aryldimethylpyrazolones with 2-benzyl vinylogous amide substituents have been identified as potent PDE3B subtype selective inhibitors. Dihydropyridazinone 8a (PDE3B IC50 = 0.19 nM, 3A IC50 = 1.3 nM) was selected for in vivo evaluation of lipolysis induction, metabolic rate increase, and cardiovascular effects. (C) 2003 Elsevier Ltd. All rights reserved.